Methylphenidate Hydrochloride 72865-0125
Product NDC
72865-0125- Manufacturer
- Xlcare Pharmaceuticals, Inc.
- Dosage Form
- Tablet, Chewable
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- March 1, 2018
- Listing Expires
- December 31, 2026
- Application
- ANDA210354
Active Ingredients
| Ingredient | Strength |
|---|---|
| Methylphenidate Hydrochloride | 2.5 mg/1 |
Drug Class
Central Nervous System Stimulant [EPC]Central Nervous System Stimulation [PE]
Packaging Options(1)
100 TABLET, CHEWABLE in 1 BOTTLE (72865-125-01)